Patents by Inventor Xiaoyan Cong

Xiaoyan Cong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRRSV SX-105 strain and use thereof
    Patent number: 10883085
    Abstract: The present invention relates to porcine reproductive and respiratory syndrome virus (PRRSV) vaccines in a field of veterinary biological products, and more particularly to a PRRSV SX-105 strain having a deposit number of CGMCC No. 9906, and a use thereof in preparing PRRSV live vaccines. PRRSV SX-1 original strains are strongly pathogenic to swine. A PRRSV SX-105 attenuated strain shows safety and good immunogenicity on the swine. The PRRSV live vaccines, prepared from the PRRSV SX-105 strain, are safe and reliable, and able to generate strong immunity after immunization. The PRRSV live vaccines significantly decrease morbidity and mortality in inoculated swine groups, and have immunization effects reaching and slightly better than conventional commercial vaccines on the market, showing advantages to compete with the same kind of products around the world. The PRRSV live vaccines are capable of effectively preventing PRRS epidemic and transmission, and has broad application prospects.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: January 5, 2021
    Assignee: Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences
    Inventors: Jiaqiang Wu, Jiang Yu, Yuyu Zhang, Xiwang Zhu, Yijun Du, Jun Li, Xiaoyan Cong, Jinbao Wang
  • PRRSV SX-105 strain and use thereof
    Publication number: 20180371424
    Abstract: The present invention relates to porcine reproductive and respiratory syndrome virus (PRRSV) vaccines in a field of veterinary biological products, and more particularly to a PRRSV SX-105 strain having a deposit number of CGMCC No. 9906, and a use thereof in preparing PRRSV live vaccines. PRRSV SX-1 original strains are strongly pathogenic to swine. A PRRSV SX-105 attenuated strain shows safety and good immunogenicity on the swine. The PRRSV live vaccines, prepared from the PRRSV SX-105 strain, are safe and reliable, and able to generate strong immunity after immunization. The PRRSV live vaccines significantly decrease morbidity and mortality in inoculated swine groups, and have immunization effects reaching and slightly better than conventional commercial vaccines on the market, showing advantages to compete with the same kind of products around the world. The PRRSV live vaccines are capable of effectively preventing PRRS epidemic and transmission, and has broad application prospects.
    Type: Application
    Filed: January 29, 2015
    Publication date: December 27, 2018
    Inventors: Jiaqiang Wu, Jiaug Yu, Yayu Zhang, Xiwang Zhu, Yijun Du, Jun Li, Xiaoyan Cong, Jinbao Wang